138 related articles for article (PubMed ID: 17115410)
1. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype.
Yagiz K; Wu LY; Kuntz CP; James Morré D; Morré DM
J Cell Biochem; 2007 May; 101(2):295-306. PubMed ID: 17115410
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype.
Yagiz K; Morré DJ; Morré DM
J Nutr Biochem; 2006 Nov; 17(11):750-9. PubMed ID: 16517149
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
4. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.
Chueh PJ; Wu LY; Morré DM; Morré DJ
Biofactors; 2004; 20(4):235-49. PubMed ID: 15706060
[TBL] [Abstract][Full Text] [Related]
5. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
[TBL] [Abstract][Full Text] [Related]
6. Catechin-vanilloid synergies with potential clinical applications in cancer.
Morré DM; Morré DJ
Rejuvenation Res; 2006; 9(1):45-55. PubMed ID: 16608395
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells.
Wang HM; Chueh PJ; Chang SP; Yang CL; Shao KN
Biofactors; 2008; 34(3):209-17. PubMed ID: 19734122
[TBL] [Abstract][Full Text] [Related]
8. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.
Paul B; Hayes CS; Kim A; Athar M; Gilmour SK
Carcinogenesis; 2005 Jan; 26(1):119-24. PubMed ID: 15375010
[TBL] [Abstract][Full Text] [Related]
9. Is the cancer protective effect correlated with growth inhibitions by green tea (-)-epigallocatechin gallate mediated through an antioxidant mechanism?
Cutter H; Wu LY; Kim C; Morré DJ; Morré DM
Cancer Lett; 2001 Jan; 162(2):149-54. PubMed ID: 11146219
[TBL] [Abstract][Full Text] [Related]
10. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
11. Cell size increased in tissues from transgenic mice overexpressing a cell surface growth-related and cancer-specific hydroquinone oxidase, tNOX, with protein disulfide-thiol interchange activity.
Yagiz K; Snyder PW; Morré DJ; Morré DM
J Cell Biochem; 2008 Dec; 105(6):1437-42. PubMed ID: 18980249
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
13. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.
Herst PM; Petersen T; Jerram P; Baty J; Berridge MV
Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
15. Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein.
Tang X; Morré DJ; Morré DM
Oncol Res; 2007; 16(12):557-67. PubMed ID: 18351130
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG
Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
Basu A; Haldar S
Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced down-regulation of tumor-associated NADH oxidase during apoptosis in transformed cells.
Mao LC; Wang HM; Lin YY; Chang TK; Hsin YH; Chueh PJ
FEBS Lett; 2008 Oct; 582(23-24):3445-50. PubMed ID: 18789934
[TBL] [Abstract][Full Text] [Related]
19. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol.
Wu LY; De Luca T; Watanabe T; Morré DM; Morré DJ
Biochim Biophys Acta; 2011 Aug; 1810(8):784-9. PubMed ID: 21571040
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
